Clinical Trials Browser

Phase 2 × oblimersen × Genitourinary × Clear all

NCT00059813 2013-08-26

Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00085228 2012-09-24

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Phase 2 Completed

Prostatic Neoplasms